Recently, we found that pathogenic founder/recurrent germline mutations in 4 genes (BRCA1, BRCA2, RAD51C, PALB2) are responsible for 12.5% of ovarian cancer cases among unselected patients in the Polish population [5]. The gene discussed is RAD51C; the disease is ovarian carcinoma.